|
Aug 12
|
Needham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PT
|
|
Aug 9
|
CorMedix Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 8
|
Cormedix Inc (CRMD) Q2 2025 Earnings Call Highlights: Strategic Acquisition and Positive ...
|
|
Aug 8
|
CorMedix signs agreement to acquire Melinta for $300m
|
|
Aug 7
|
Sector Update: Health Care Stocks Decline Late Afternoon
|
|
Aug 7
|
CorMedix to Buy Melinta Therapeutics for $300 Million
|
|
Aug 7
|
CorMedix (CRMD) Surpasses Q2 Earnings and Revenue Estimates
|
|
Aug 7
|
CorMedix: Q2 Earnings Snapshot
|
|
Aug 7
|
Melinta Therapeutics Announces Strategic Acquisition by CorMedix, Underscoring Its Portfolio Value and Industry Leadership
|
|
Aug 7
|
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
|
|
Aug 7
|
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
|
|
Aug 6
|
CorMedix (CRMD) Earnings Expected to Grow: What to Know Ahead of Q2 Release
|
|
Aug 1
|
Does CorMedix (CRMD) Have the Potential to Rally 65.64% as Wall Street Analysts Expect?
|
|
Jul 24
|
CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock?
|
|
Jun 30
|
Circle initiated, Disney upgraded: Wall Street's top analyst calls
|
|
Jun 30
|
Company News for Jun 30, 2025
|
|
Jun 27
|
Upgrade: Analysts Just Made A Captivating Increase To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts
|
|
Jun 27
|
CorMedix Inc. Announces Pricing of Public Offering of Common Stock
|
|
Jun 26
|
CorMedix Inc. Announces Proposed Public Offering of Common Stock
|
|
Jun 24
|
CorMedix announces customer implementation
|